Compare Novartis AG (NVS) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Vertiv Holdings Co — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vertiv Holdings Co trades at $305.58 (market cap $112.03B). The key difference: Novartis AG is far larger — about 2.6× Vertiv Holdings Co's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | VRT | |
|---|---|---|
Market Cap | $290.25B | $112.03B |
Sector | Health | Technology |
52-Week High | $168.62 | $376.23 |
52-Week Low | $113.50 | $121.82 |
Enterprise Value | $330.27B | $112.80B |
Dividend Yield | 3.17% | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
